Ім'я файлу: послеродовые_кровотечения.pdf
Розширення: pdf
Розмір: 1529кб.
Дата: 12.04.2021
скачати

Проведение коррекции нарушений в системе гемостаза
Да/нет
Заказ Sell Saver
Да/нет
Оценка лабораторных показателей
Да/нет
Коммуникация с другими членами команды
Да/нет
Другое
Да/нет
Приложение Г4.
Протокол консилиума для назначения лекарственных препаратов при состояниях,
угрожающих жизни, при наличии расхождения с инструкцией по применению, в
соответствии со стандартами оказания медицинской помощи, клиническими
протоколами и клиническими рекомендациями
Скачать в формате Microsoft Word
Скачать в формате Adobe PDF
1. Tier Н, Schlembach D, Korte W, von Heymann C, Steppat S, Kuhnert M, Maul H, Henrich
W, Rath W, Wacker J, Kainer F, Surbek D, Helmer H. [The new German guideline on postpartum haemorrhage (PPH): essential aspects for coagulation and circulatory therapy].
Anasthesiol Intensivmed Notfallmed Schmerzther. 2016;51(9):526-35. doi: 10.105 5/s- 0042-
105937.
↩
↩
2. Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt B, Riris S, Thomson A. on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and
Management of Postpartum Haemorrhage. ВJOG An Int J Obstet Gynaecol.
2017;124(5):el06-49. doi: 10.1111/1471-
0528.14178.
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
3. Takeda S, Makino S, Takeda J, Kanayama N, Kubo T, Nakai A, Suzuki S, Seki H, Terui K,
Inaba S, Miyata S. Japanese Clinical Practice Guide for Critical Obstetrical Hemorrhage
(2017 revision). J Obstet Gynaecol Res. 2017;43(10):1517-21. doi:10.1111/jog.13417.
↩
↩
↩

4. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum
Hemorrhage. Obstet Gynecol. 2017;130(4):el68-86. doi: 10.1097/AOG.00000000000023 51.
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
↩
5. LeBasA., Chandraharan E., Addei A. AS. Use of the “obstetric shock index” as an adjunctinid entify in signify cant blood loss in patients with massive postpartum hemorrhage.
IntJ GynaecolObstet. 2014;124(3):253-5.
↩
↩
6. Shields LE, Wiesner S, Fulton J, Pelletreau B. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety. Am J Obstet Gynecol.
2015;212(3):272-80. doi:10.1016/j.ajog.2014.07.012.
↩
7. Russell RT. WHO guidelines for the management of postpartum haemorrhage and retained placenta. Hum Fertil. 2011; 14(2): 129-129. doi:
10.3109/14647273.2010.529650.
↩
↩
↩
↩
↩
8. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008;22(6):999- 1012. doi:10.1016/j.bpobgyn.2008.08.004.
↩
↩
9. Say L, Chou D, Gemmill A, Tunçalp O, Moller A-В, Daniels J, Gulmezoglu AM,
TemmermanM, Alkema L. Global causes of maternal death: a WHO systematic analysis.
Lancet Glob Heal. 2014;2(6):e323-33. doi:10.1016/S2214-109X(14)70227-X.
↩
10. Creanga AA, Berg CJ, Ko JY, Farr SL, Tong VT, Bruce FC, Callaghan WM. Maternal mortality and morbidity in the United States: where are we now? J Womens Health
(Larchmt). 2014;23(l):3-9. doi:10.1089/jwh.2013.4617.
↩
11. Mallett S. AM. Point-of-care monitoring of haemostasis. Anaesthesia. 2015;70(l):73-7.
↩
12. Fowler A. PD. Laboratory monitoring of haemostasis. Anaesthesia. 2015;70(l):68-72.
↩
13. Brooks M, Legendre G, Brun S, Bouet P-E, Mendes LP, Merlot B, Sentilhes L. Use of a
Visual Aid in addition to a Collector Bag to Evaluate Postpartum Blood loss: A Prospective
Simulation Study. Sci Rep. 2017;7:46333. doi:10.1038/srep46333.
↩
↩
14. Lilley G, Burkett-St-Laurent D, Precious E, Bruynseels D, Kaye A, Sanders J, Alikhan R,
Collins PW, Hall JE, Collis RE. Measurement of blood loss during postpartum haemorrhage.
Int J Obstet Anesth. 2015;24(l):8-14. doi:10.1016/j.ijoa.2014.07.009.
↩
15. Diaz V, Abalos E CG. Methods for blood loss estimation after vaginal birth. Cochrane
Database Syst Rev. 2018;Sep13(9).
↩
16. Patel A, Goudar SS, Geller SE,Kodkany BS, Edlavitch SA, Wagh K, Patted SS, Naik VA,
Moss N, Derman RJ. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. IntJ Gynaecol Obstet. 2006;93(3):220-4. doi:10.1016/j.ijgo.2006.02.014.
↩

17. Glover P. Blood loss at delivery: how accurate is your estimation? Aust J Midwifery. 2003;
16(2):21-4.
↩
18. Al Kadri HMF, Al Anazi BK, Tamim HM. Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study. Arch Gynecol Obstet.
2011 ;283(6): 1207-13. doi: 10.1007/s00404-010-1522-1.
↩
19. Zuckerwise LC, Pettker CM, Illuzzi J, Raab CR, Lipkind HS. Use of a novel visual aid to improve estimation of obstetric blood loss. Obstet Gynecol. 2014;123(5):982-6. doi:
10.1097/AOG.0000000000000233.
↩
20. Girault A, Deneux-Tharaux C, Sentilhes L, Maillard F, Goffinet F. Undiagnosed abnormal postpartum blood loss: Incidence and risk factors. PLoS One. 2018; 13(l):e0190845. doi:
10.1371/joumal.pone.0190845.
↩
21. American College of Surgeons Committee on Trauma. ATLS® Student Manual 9th Edition.
Chicago, IL: American College of Surgeons. 2012.
↩
↩
22. Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, Brocklehurst P KJ. Surveillance of maternal deaths in the UK 2012-14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-14. 2016.
↩
23. Green M, Rider C, RatcliffD, Woodring BC. Developing a Systematic Approach to Obstetric
Emergencies. J Obstet Gynecol neonatal Nurs JOGNN. 44(5):677-82. doi: 10.1111/1552-
6909.12729.
↩
24. Bajaj K, Rivera-Chiauzzi EY, Lee C, Shepard C, Bernstein PS, Moore-Murray T, Smith H,
Nathan L, Walker K, Chazotte C, GoffmanD. Validating Obstetric Emergency Checklists using Simulation: A Randomized Controlled Trial. Am J Perinatal. 2016;33(12): 1182-90. doi:10.1055/s-0036-1586118.
↩
25. Guise J-M, Mladenovic J. In situ simulation: identification of systems issues. Semin
Perinatal. 2013;37(3):161-5. doi:10.1053/j.semperi.2013.02.007.
↩
26. Guise J-M, Lowe NK, Deering S, Lewis PO, О’Haire C, Irwin LK, Blaser M, Wood LS,
Kanki BG. Mobile in situ obstetric emergency simulation and teamwork training to improve maternal-fetal safety in hospitals. Jt Comm J Qual patient Saf. 2010;36(10):443-53.
↩
27. Obstetric Care Consensus No. 5: Severe Maternal Morbidity: Screening and Review. Obstet
Gynecol. 2016;128(3):e54-60. doi: 10.1097/AOG.0000000000001642.
↩
28. American College of Obstetricians and Gynecologists Committee on Patient Safety and
Quality Improvement. Committee opinion no. 590: preparing for clinical emergencies in obstetrics and gynecology. Obstet Gynecol. 2014;123(3):722-5. doi: 10.1097/01.
AOG.0000444442.04111 ,c6.
↩
29. Likis F, Sathe N, Morgans A, Hartmann K, Young J, Carlson-Bremer D, Schorn M, Surawicz
T, Andrews J. Management of Postpartum Hemorrhage. Comparative Effectiveness Review

No. 151. (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No.
290-2012-00009-1.) AHRQ Publication No. 15-EHC013-EF. Rockville, MD: Agency for
Healthcare Researc.
↩
↩
↩
↩
30.
Рекомендации ВОЗ по профилактике и лечению послеродового кровотечения, 2012. -
43 с.
↩
↩
↩
↩
↩
↩
↩
↩
31. Gutierrez МС, Goodnough LT, Druzin М, Butwick AJ. Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. Int J Obstet
Anesth. 2012;21(3):230-5. doi:10.1016/j.ijoa.2012.03.005.
↩
↩
32. Ahonen J, Jokela R, Korttila K. An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage. Acta Anaesthesiol Scand. 2007;51(7):929-
↩
↩
33. Grottke O, Levy JH. Prothrombin complex concentrates in trauma and perioperative bleeding. Anesthesiology. 2015;122(4):923-31. doi:10.1097/ALN.0000000000000608.
↩
↩
↩
34. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet (London,
England). 2017;389(10084):2105-16. doi:10.1016/S0140-6736(17)30638-4.
↩
↩
↩
↩
↩
↩
35. Schlembach D, Helmer H, Henrich W, von Heymann C, Kainer F, Korte W, Kuhnert M, Lier
H, Maul H, Rath W, Steppat S, SurbekD, Wacker J. Peripartum Haemorrhage, Diagnosis and
Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No.
015/063, March 2016). Geburtshilfe Frauenheilkd. 2018;78(4):382-
↩
↩
↩
↩
↩
36. Tevet A, Grisaru-Granovsky S, Samueloff A, Ioscovich A. Peripartum use of cell salvage, a university practice audit and literature review. Arch Gynecol Obstet. 2012;285(2):281-4. doi:
10.1007/S00404-011-2164-7.
↩
37. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion. 2007;47(9): 1564-72. doi:10.1111/j.l537-
2995.2007.01404.x.
↩
↩
38. Dzik WH, Blajchman MA, Fergusson D, Hameed M, Henry B, Kirkpatrick A W, Korogyi T,
Logsetty S, Skeate RC, Stanworth S, MacAdams C, Muirhead B. Clinical review: Canadian
National Advisory Committee on Blood and Blood Products—Massive transfusion consensus conference 2011: report of the panel. CritCare. 2011;15(6):242. doi: 10.1186/CC10498.
↩
39. Mavrides E, Allard S, Chaandraharan E et al. On behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. В JORG.
2016; 124.
↩

40. Berg CJ, Harper MA, Atkinson SM, Bell EA, Brown HL, Hage ML, Mitra AG, Moise KJ,
Callaghan WM. Preventability of pregnancy-related deaths: results of a state-wide review.
Obstet Gynecol. 2005; 106(6): 1228-34. doi: 10.1097/01.AOG.0000187894.71913.e8.
↩
41. Clark SL, Belfort MA, Dildy GA, Herbst MA, Meyers JA, Hankins GD. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet
Gynecol. 2008;199(l):36.el-5; discussion 91-2. e7-ll. doi:10.1016/j.ajog.2008.03.007.
↩
42. Callaghan WM, Kuklina E V, Berg CJ. Trends in postpartum hemorrhage: United States,
1994-2006. Am J Obstet Gynecol. 2010;202(4):353.el-6. doi:10.1016/j.ajog.2010.01.011.
↩
43. Callaghan WM, Mackay AP, Berg CJ. Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991-2003. Am J Obstet Gynecol. 2008; 199(2):
133.el-8. doi:10.1016/j.ajog.2007.12.020.
↩
44. Kavle JA, Stoltzfus RJ, Witter F, Tielsch JM, Khalfan SS, Caulfield LE. Association between anaemia during pregnancy and blood loss at and after delivery among women with vaginal births in Pemba Island, Zanzibar, Tanzania. J Health Popul Nutr. 2008;26(2):232-40.
↩
45. Soltani H, Hutchon DR, Poulose TA. Timing of prophylactic uterotonics for the third stage of labour after vaginal birth. Cochrane database SystRev. 2010;(8):CD006173. doi:10.1002/14651858.CD006173.pub2.
↩
46. Oladapo ОТ, Okusanya BO, Abalos E. Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour. Cochrane database Syst Rev. 2018;9:CD009332. doi:10.1002/14651858.CD009332.pub3.
↩
47. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane database Syst Rev. 2014;(2):CD003249. doi:
10.1002/14651858.CD003249.pub3.
↩
48. Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane database Syst Rev. 2013;(10):CD001808. doi:10.1002/14651858.CD001808.pub2.
↩
49. Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane database SystRev. 2015;(6):CD007872. doi:
10.1002/14651858.CD007872.pub3.
↩
↩
↩
50. Franchini M, Mengoli C, Cruciani M, Bergamini V, Presti F, Marano G, Pupella S, Vaglio S,
Masiello F, Veropalumbo E, Piccinini V, Pati I, Liumbruno GM. Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis. Blood Transfus. 2018;16(4):329-37. doi:10.2450/2018.0026-18.
↩
↩
↩
↩
↩
51. Shakur H, Beaumont D, Pavord S, Gayet-Ageron A, Ker K, Mousa HA. Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane database Syst Rev.
2018;2:CD012964. doi:10.1002/14651858.CD012964.
↩
↩
↩
↩
↩
↩

52. WHO Guidelines Approved by the Guidelines Review Committee. WHO recommendations:
Uterotonics for the prevention of postpartum haemorrhage. Geneva: World Health
Organization; 2018.
↩
↩
↩
↩
53. JinB, Du Y, Zhang F, Zhang K, Wang L, Cui L. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Matem
Fetal Neonatal Med. 2016;29(3):400-7. doi’.lO.3109/14767058.2014.1002394.
↩
↩
54. Su L-L, Chong Y-S, Samuel M. Carbetocin for preventing postpartum haemorrhage.
Cochrane database Syst Rev. 2012;(4):CD005457. doi:
10.1002/14651858.CD005457.pub4.
↩
55. Su L-L, Chong Y-S, Samuel M. Carbetocin for preventing postpartum haemorrhage.
Cochrane database Syst Rev. 2012;(4):CD005457. doi:
10.1002/14651858.CD005457.pub4.
↩
56. Anandakrishnan S, BalkiM, Farine D, Seaward G, Carvalho JCA. Carbetocin at elective
Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2. Can J
Anaesth. 2013;60(ll): 1054-60. doi:10.1007/sl2630-013-0028-2.
↩
↩
57. Dyer RA, van Dyk D, Dresner A. The use of uterotonic drugs during caesarean section. Int J
Obstet Anesth. 2010;19(3):313-9. doi:10.1016/j.ijoa.2010.04.011.
↩
↩
58. WHO recommendations: uterotonics for the prevention of postpartum haemorrhage. World
Heal Organ. 2018;53 p.
↩
↩
59. Leung SW, Ng PS, Wong WY, Cheung TH. A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour. BJOG. 2006; 113(12): 1459- 64. doi: 10.1111/j. 1471-0528.2006.01105.x.
↩
60. Шифман E.M., Куликов A.B. ПДНидр. Анестезия и интенсивная терапия при массивной кровопотере в акушерстве. Клинические рекомендации (протоколы лечения). Вопросы акушерства, гинекологии, перинатологии. 2018; 17(3):81—100.
↩
61. Cannon JW. Hemorrhagic Shock. N Engl J Med. 2018;378(4):370-9. doi: 10.1056/NEJMral
705649.
↩
↩
62. Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A,
Pinsky MR, Teboul JL, Vincent JL, Rhodes A. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.
Intensive Care Med. 2014;40(12): 1795-815. doi:10.1007/s00134-014-3525-z.
↩
↩
↩
63. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated
Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis
(ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5): 1327-30.
↩

64. Squizzato A, Hunt BJ, Kinasewitz GT, Wada H, Ten Cate H, Thachil J, Levi M, Vicente V,
D Angelo A, Di Nisio M. Supportive management strategies for disseminated intravascular coagulation. An international consensus. Thromb Haemost. 2016; 115(5):896-904. doi
:10.1160/TH15-09-0740.
↩
65. Erez O. Disseminated intravascular coagulation in pregnancy - Clinical phenotypes and diagnostic scores. Thromb Res. 2017;151 Suppl:S56—S60. doi:10.1016/S0049-
3848(17)30069-5.
↩
66. Clark SL, Romero R, Dildy GA, Callaghan WM, Smiley RM, Bracey A W, Hankins GD, D
Alton ME, Foley M, Pacheco LD, Vadhera RB, Herlihy JP, Berkowitz RL, Belfort MA.
Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2016;215(4):408-12. doi:10.1016/j.ajog.2016.06.037.
↩
67. Lyndon A, Lagrew D, Shields L, Main E, Cape V. Improving health care response to obstetric hemorrhage version 2.0. A California quality improvement toolkit. Stamford (CA):
California Maternal Quality Care Collaborative; Sacramento (CA): California Department of
Public Health. 2015;
↩
68. Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) to monitor haemostatic treatment in bleeding patients: a systematic review with meta-analysis and trial sequential analysis. Anaesthesia. 2017; 72(4):
519-31. doi: 10.1111/anae. 13765.
↩
69. Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane database Syst Rev. 2016;(8):CD007871. doi:
10.1002/14651858.CD007871.pub3.
↩
↩
70. FahrendorffM, Oliveri RS, Johansson PI. The use of viscoelastic haemostatic assays in goal- directing treatment with allogeneic blood products - A systematic review and meta- analysis.
Scand J Trauma Resusc Emerg Med. 2017;25(l):39. doi:10.1186/sl3049-017- 0378-9.
↩
71. Whiting P,Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J,

1   2   3   4   5   6   7   8

скачати